June 16, 2022
(press release)
–
Pharmaceutical companies have a heightened interest in sustainable practices. Some of the largest pharma companies in the industry have recently committed to sustainability goals regarding emissions, with most companies focusing on carbon footprint. Critical processes in the pharma industry that contribute to carbon footprint are the production of pharmaceutical products, production of pharmaceutical packaging, supply chain, and end-of-life disposal. Although packaging is only a share of the overall impact, packaging suppliers can support the pharmaceutical industry’s goals by considering environmental impact when designing packaging. Comparing different materials and designs through a Life Cycle Assessment system allows suppliers to make informed decisions on what materials and package formats to use. Amcor’s Advanced Sustainability Stewardship Evaluation Tool (ASSET™) is a proprietary tool for Life Cycle Assessments (LCAs) that measures the environmental impact from raw materials to end-of-use, offering a simple and effective way to compare two packages. Understand how your packaging affects the environment It can be tough to comprehend the frequently unseen environmental impact of your packaging. Amcor’s Life Cycle Assessment (LCA) tool was created to examine the environmental impact at each stage of a product's life cycle. ASSET™ Life Cycle Assessment provides a detailed and fact-based evaluation of different packaging choices by looking at the full life cycle, including the extraction of raw materials, production and usage, through to end of life. Case Study: Amcor HealthCare™ AmSky™ Blister System
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
